Search Results

There are 4521 results for: content related to: Weight gain associated with taking psychotropic medication: An integrative review

  1. Olanzapine alone or in combination for acute mania

    Intervention Review

    The Cochrane Library

    Jennifer M Rendell, Harm J Gijsman, Paul K Keck, Guy Goodwin and John Geddes

    Published Online : 20 JAN 2003, DOI: 10.1002/14651858.CD004040

  2. Atypical antipsychotics for aggression and psychosis in Alzheimer's disease

    Intervention Review

    The Cochrane Library

    Clive G Ballard, Jonathan Waite and Jacqueline Birks

    Published Online : 25 JAN 2006, DOI: 10.1002/14651858.CD003476.pub2

  3. Pharmacological interventions for borderline personality disorder

    Intervention Review

    The Cochrane Library

    Jutta Stoffers, Birgit A Völlm, Gerta Rücker, Antje Timmer, Nick Huband and Klaus Lieb

    Published Online : 16 JUN 2010, DOI: 10.1002/14651858.CD005653.pub2

  4. You have free access to this content
    Olanzapine pamoate: a stick in time?

    International Journal of Clinical Practice

    Volume 63, Issue 1, January 2009, Pages: 140–150, L. Citrome

    Version of Record online : 1 OCT 2008, DOI: 10.1111/j.1742-1241.2008.01900.x

  5. Metabolic side effects of antipsychotic medication

    International Journal of Clinical Practice

    Volume 61, Issue 8, August 2007, Pages: 1356–1370, A. Tschoner, J. Engl, M. Laimer, S. Kaser, M. Rettenbacher, W. W. Fleischhacker, J. R. Patsch and C. F. Ebenbichler

    Version of Record online : 10 JUL 2007, DOI: 10.1111/j.1742-1241.2007.01416.x

  6. Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain?

    Acta Psychiatrica Scandinavica

    Volume 111, Issue 3, March 2005, Pages: 177–184, W. V. R. Vieweg, A. B. Sood, A. Pandurangi and J. J. Silverman

    Version of Record online : 8 FEB 2005, DOI: 10.1111/j.1600-0447.2004.00444.x

  7. You have free access to this content
    Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic

    International Journal of Clinical Practice

    Volume 63, Issue 12, December 2009, Pages: 1762–1784, L. Citrome

    Version of Record online : 14 OCT 2009, DOI: 10.1111/j.1742-1241.2009.02228.x

  8. Pharmacological treatment of acute agitation associated with psychotic and bipolar disorder: a systematic review and meta-analysis

    Human Psychopharmacology: Clinical and Experimental

    Volume 31, Issue 4, July 2016, Pages: 268–285, Yenal Dundar, Janette Greenhalgh, Marty Richardson and Kerry Dwan

    Version of Record online : 5 MAY 2016, DOI: 10.1002/hup.2535

  9. Novel antipsychotics in bipolar and schizoaffective mania

    Acta Psychiatrica Scandinavica

    Volume 109, Issue 6, June 2004, Pages: 405–419, G. J. R. Mensink and C. J. Slooff

    Version of Record online : 29 APR 2004, DOI: 10.1111/j.1600-0047.2004.00295.x

  10. Second-generation antipsychotic effect on cognition in patients with schizophrenia—a meta-analysis of randomized clinical trials

    Acta Psychiatrica Scandinavica

    Volume 131, Issue 3, March 2015, Pages: 185–196, R. E. Nielsen, S. Levander, G. Kjaersdam Telléus, S. O. W. Jensen, T. Østergaard Christensen and S. Leucht

    Version of Record online : 16 JAN 2015, DOI: 10.1111/acps.12374

  11. You have free access to this content
    Benzodiazepines for psychosis-induced aggression or agitation

    Intervention Review

    The Cochrane Library

    Donna Gillies, Stephanie Sampson, Alison Beck and John Rathbone

    Published Online : 30 APR 2013, DOI: 10.1002/14651858.CD003079.pub3

  12. You have free access to this content
    A systematic review of metformin to limit weight-gain with atypical antipsychotics

    Journal of Clinical Pharmacy and Therapeutics

    Volume 36, Issue 5, October 2011, Pages: 537–545, Y. J. Lee and J. H. Jeong

    Version of Record online : 21 MAR 2011, DOI: 10.1111/j.1365-2710.2011.01255.x

  13. The analysis of antipsychotic drugs in human matrices using LC-MS(/MS)

    Drug Testing and Analysis

    Volume 4, Issue 6, June 2012, Pages: 376–394, Eva Saar, Jochen Beyer, Dimitri Gerostamoulos and Olaf H. Drummer

    Version of Record online : 10 MAY 2012, DOI: 10.1002/dta.1337

  14. Practitioner Review: Schizophrenia spectrum disorders and the at-risk mental state for psychosis in children and adolescents – evidence-based management approaches

    Journal of Child Psychology and Psychiatry

    Volume 54, Issue 11, November 2013, Pages: 1155–1175, Paul A. Tiffin and Patrick Welsh

    Version of Record online : 14 SEP 2013, DOI: 10.1111/jcpp.12136

  15. A Systematic Review of the Efficacy and Safety of Atypical Antipsychotics in Patients with Psychological and Behavioral Symptoms of Dementia

    Journal of the American Geriatrics Society

    Volume 54, Issue 2, February 2006, Pages: 354–361, Susan Carson, Marian S. McDonagh and Kim Peterson

    Version of Record online : 2 DEC 2005, DOI: 10.1111/j.1532-5415.2005.00566.x

    Corrected by:


    Vol. 54, Issue 9, 1479, Version of Record online: 7 SEP 2006

  16. You have free access to this content
    Employing proteomics to unravel the molecular effects of antipsychotics and their role in schizophrenia

    PROTEOMICS - Clinical Applications

    Volume 10, Issue 4, April 2016, Pages: 442–455, Juliana S. Cassoli, Paul C. Guest, Aline G. Santana and Daniel Martins-de-Souza

    Version of Record online : 25 JAN 2016, DOI: 10.1002/prca.201500109

  17. Electromyographic analysis of masseter and temporal muscles, bite force, masticatory efficiency in medicated individuals with schizophrenia and mood disorders compared with healthy controls

    Journal of Oral Rehabilitation

    Volume 41, Issue 6, June 2014, Pages: 399–408, R. H. de Oliveira, J. E. C. Hallak, S. Siéssere, L. G. de Sousa, M. Semprini, M. F. de Sena, F. de L. Osorio, E. A. Nunes, J. P. Pinto and S. C. H. Regalo

    Version of Record online : 25 MAR 2014, DOI: 10.1111/joor.12164

  18. Selegiline Transdermal System: An Examination of the Potential for CYP450-Dependent Pharmacokinetic Interactions With 3 Psychotropic Medications

    The Journal of Clinical Pharmacology

    Volume 47, Issue 2, February 2007, Pages: 146–158, Dr Albert J. Azzaro, Dr John Ziemniak, Ms Eva Kemper, Dr Bryan J. Campbell and Dr Chad VanDenBerg

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270006296151

  19. Treatment with olanzapine, risperidone or typical antipsychotic drugs in Asian patients with schizophrenia

    Australian and New Zealand Journal of Psychiatry

    Volume 40, Issue 5, May 2006, Pages: 437–445, Chul Lee, Kuang-Hsien Wu, Hussain Habil, Yulia Dyachkova and Phil Lee

    Version of Record online : 9 MAY 2006, DOI: 10.1111/j.1440-1614.2006.01820.x

  20. New generation antipsychotics for first episode schizophrenia

    Intervention Review

    The Cochrane Library

    Johannes Hamann, Werner Kissling, Stefan Leucht and Christine Rummel-Kluge

    Published Online : 20 OCT 2003, DOI: 10.1002/14651858.CD004410